Understanding Long COVID
Long COVID can affect nearly every aspect of daily life, from energy levels and memory to breathing, heart function, sleep, and the ability to work or exercise. Because symptoms vary widely from person to person, effective care requires a comprehensive evaluation that looks beyond any single diagnosis or treatment.
At APNS, our providers take an individualized, evidence-informed approach to Long COVID and related post-viral conditions. We review your medical history, symptom timeline, previous testing, and overall health to develop a personalized treatment plan that may include diagnostic evaluation, prescription medications, lifestyle recommendations, nutritional support, and ongoing follow-up.
What Is Long COVID?
Long COVID—also called Post-COVID Conditions or post-acute sequelae of SARS-CoV-2 infection (PASC)—is a chronic condition that follows SARS-CoV-2 infection and is present for at least three months. Symptoms may begin during the acute illness, appear after apparent recovery, improve and return, or change over time. Long COVID can affect one or several organ systems and may occur even after a mild or initially asymptomatic infection.
Long COVID is not one single disease process. It is better understood as a collection of overlapping biological patterns. Two patients may have similar fatigue or brain fog for different reasons and may therefore respond differently to the same treatment.
What Does “Vaccine Injury” Mean?
“Vaccine injury” is a broad patient-facing term. It may refer to a recognized adverse event—such as anaphylaxis, myocarditis or pericarditis, thrombosis with thrombocytopenia after certain adenoviral-vector vaccines, or a rare neurologic complication—or to persistent symptoms beginning after vaccination that do not fit one established diagnosis.
Researchers sometimes call the latter post-vaccination syndrome (PVS). Reported symptoms can overlap substantially with Long COVID, including fatigue, post-exertional symptom worsening, brain fog, dysautonomia, neuropathic sensations, sleep disruption, tinnitus, headache, and exercise intolerance. PVS is being actively studied, but it does not yet have universally accepted diagnostic criteria, a validated diagnostic test, or a proven single mechanism.
APNS Perspective
Patients deserve careful evaluation whether symptoms began after infection, vaccination, or both. A temporal relationship is clinically relevant, but timing alone does not prove one mechanism. APNS considers known adverse events, prior infections, alternative diagnoses, and the patient’s complete symptom pattern.
Who Can Develop Long COVID?
- Adults and children
- People who had mild, moderate, or severe acute COVID-19
- People who were hospitalized and people who were never hospitalized
- Vaccinated or unvaccinated individuals
- People with repeated infections
- People without major previous medical conditions
Factors Associated With Greater Risk
- More severe acute infection or hospitalization
- Repeated SARS-CoV-2 infections
- Older age, although young adults and children can be affected
- Female sex in many cohorts
- Certain pre-existing medical conditions
- Possible immune, metabolic, hormonal, genetic, or autonomic susceptibility
How Long Can It Last?
Some patients improve within months; others experience symptoms for years. Recovery is often uneven. A patient may improve overall while continuing to have relapses after physical exertion, cognitive activity, illness, stress, heat, dehydration, or poor sleep. Long COVID can be disabling even when routine tests are normal.Signs, Symptoms, and Clinical Patterns
Common Signs and Symptoms
Long COVID can affect multiple organ systems, and symptoms vary widely from person to person. Some people experience only a few mild symptoms, while others have persistent or fluctuating symptoms that interfere with daily activities, work, or exercise tolerance.
| System or Pattern | Possible Symptoms |
|---|---|
| Energy and exertion | Fatigue that interferes with daily life; post-exertional malaise or post-exertional symptom exacerbation; reduced stamina; prolonged recovery after activity. |
| Brain and nervous system | Brain fog, slowed processing, memory difficulty, headache, migraine, dizziness, altered smell or taste, tingling, burning, neuropathic discomfort, tremor, sound or light sensitivity. |
| Autonomic nervous system | Rapid heart rate when standing, lightheadedness, faintness, temperature intolerance, sweating changes, blood-pressure instability, digestive motility changes; may resemble POTS. |
| Heart and circulation | Palpitations, chest discomfort, exercise intolerance, shortness of breath, vascular symptoms; serious cardiac causes must be excluded. |
| Lungs | Persistent cough, breathlessness, chest tightness, reduced exercise capacity. |
| Sleep and mood | Unrefreshing sleep, insomnia, excessive sleepiness, anxiety, depressed mood, irritability; these may be consequences, contributors, or parallel conditions. |
| Digestive system | Nausea, diarrhea, constipation, abdominal discomfort, bloating, reflux, appetite change, food intolerance. |
| Immune or allergy-like | Flushing, itching, hives, nasal symptoms, wheezing, food or medication sensitivity; sometimes discussed as a mast-cell activation pattern. |
| Muscles and joints | Muscle aches, joint discomfort, weakness, stiffness, reduced endurance. |
| Other | Tinnitus, hair shedding, rash, menstrual-cycle changes, sexual dysfunction, feverishness, swollen glands, or symptom flares after reinfection. |
Post-Exertional Malaise Is Not Ordinary Tiredness
Post-exertional malaise (PEM) is a delayed worsening of symptoms after physical, cognitive, emotional, or sensory effort that previously would have been tolerated. The flare may begin hours or a day later and last days or longer. When PEM is present, fixed graded exercise that repeatedly pushes beyond the patient’s limit may worsen the condition. Activity should be paced and individualized.
Common Clinical Phenotypes
- Fatigue/PEM or ME/CFS-like pattern
- Dysautonomia or POTS-like pattern
- Neurocognitive and neuropathic pattern
- Respiratory or cardiopulmonary pattern
- Mast-cell or histamine-related symptom pattern
- Pain and inflammatory pattern
- Gastrointestinal and microbiome-related pattern
- Post-intensive-care or organ-injury pattern
- Mixed multisystem pattern
How Long COVID Affects Daily Life
- Difficulty working full-time or maintaining attendance
- Reduced ability to exercise, shop, cook, drive, or provide childcare
- Need for additional rest, pacing, mobility support, or workplace accommodations
- Reduced social participation and independence
- Financial stress, uncertainty, grief, anxiety, or depression related to loss of function
Symptoms Are Real Even When Routine Tests Are Normal
Long COVID is diagnosed clinically. Normal routine laboratory results do not exclude it. At the same time, new or worsening symptoms must be evaluated for other treatable or urgent conditions.
Symptoms Requiring Urgent Evaluation
- New or severe chest pressure, trouble breathing, fainting, blue lips, or oxygen decline
- Stroke-like symptoms, new weakness, confusion, seizure, or severe sudden headache
- Sustained very rapid or irregular heart rhythm
- Coughing or vomiting blood, black stool, or significant bleeding
- Suicidal thoughts or inability to maintain hydration or basic self-care
Why Long COVID May Happen
Overlapping Biological Theories
Researchers believe Long COVID likely results from multiple overlapping biological processes rather than a single cause. The importance of each mechanism may differ from one person to another, and many of these theories continue to be actively studied.
| Proposed Mechanism | How It May Contribute |
|---|---|
| Viral persistence or residual antigen | Viral RNA, proteins, or reservoirs may persist in tissues in some patients and continue stimulating immune activity. Whether this represents replicating virus, noninfectious remnants, or both may differ by patient. |
| Immune dysregulation and autoimmunity | Altered T-cell, B-cell, cytokine, complement, antibody, or innate immune responses may continue after infection and may damage tissues or disrupt normal signaling. |
| Endothelial and microvascular dysfunction | Injury to blood-vessel lining, platelet activation, impaired vascular regulation, and thrombo-inflammation may reduce effective tissue perfusion. “Microclot” theories remain under study and are not diagnosed by a validated routine clinical test. |
| Autonomic nervous-system dysfunction | Abnormal heart-rate, blood-pressure, vascular, digestive, and temperature regulation may produce POTS-like illness, dizziness, palpitations, fatigue, and exercise intolerance. |
| Mitochondrial and metabolic dysfunction | Changes in cellular energy production, oxygen use, redox balance, and substrate metabolism may contribute to fatigue, PEM, and reduced exercise capacity. |
| Latent-virus reactivation | EBV and other latent viruses may reactivate in a subset of patients, potentially adding fatigue, immune activation, or neurologic symptoms. |
| Mast-cell and histamine signaling | Mast-cell mediator release may contribute to flushing, itching, tachycardia, wheezing, gastrointestinal symptoms, and food or medication sensitivities in some patients. |
| Gut dysbiosis and barrier disruption | Changes in the microbiome and intestinal barrier may influence inflammation, immunity, nutrient handling, and gut–brain signaling. |
| Tissue injury and impaired repair | Direct organ injury, hospitalization, clotting, deconditioning, or altered repair responses may produce persistent cardiopulmonary, neurologic, or muscular limitations. |
| Neuroinflammation and brain-body signaling | Microglial activation, blood-brain barrier disruption, vagal signaling changes, or altered sensory processing may contribute to brain fog, pain, sleep problems, mood changes, and autonomic symptoms. |
Why One Treatment Does Not Help Everyone
A medication may target inflammation but not dysautonomia; another may improve sleep or neuropathic discomfort without affecting viral persistence. Some patients may have several mechanisms operating at once. Treatment is therefore usually layered: exclude dangerous conditions, treat recognized diagnoses, manage dominant symptoms, reduce relapse triggers, and cautiously test selected therapies with clear goals and stop rules.
Long COVID and Post-Vaccination Symptoms May Overlap
Long COVID and reported PVS can share immune, neurologic, vascular, autonomic, and mast-cell-like features. Prior infection may also be unrecognized, making attribution difficult. The overlap does not establish that the conditions are identical, and research into PVS remains preliminary.
No Single Validated Biomarker
There is currently no one blood test, cytokine panel, clot test, antibody value, or spike-protein result that confirms or grades Long COVID for routine clinical care. Diagnosis rests on the history, symptom pattern, functional change, examination, and testing directed at competing diagnoses or specific complications.
Spike Proteins and Long COVID
What Is the Spike Protein?
The spike protein is a surface protein SARS-CoV-2 uses to attach to and enter human cells. During infection, the body encounters spike as part of the virus. COVID-19 vaccines expose the immune system to spike antigen or instructions for producing it temporarily so protective immune responses can develop.
The Persistent Spike or Antigen Theory
Researchers have detected SARS-CoV-2 antigens, RNA, or protein fragments in blood or tissues in some people after acute infection. Proposed sources include tissue reservoirs, persistent viral material, delayed clearance, or release from affected tissues. Persistent antigen could theoretically maintain immune activation, complement signaling, endothelial irritation, abnormal clotting pathways, autoantibody production, or neuroinflammation.
A small exploratory study of people reporting chronic symptoms after vaccination also found immune differences and detectable circulating spike in some participants long after vaccination. Those findings are hypothesis-generating. The study was small, cross-sectional, included prior infection in many participants, and did not establish that spike caused the symptoms.
Why Spike Levels Do Not Tell the Whole Story
Researchers continue to study whether persistent SARS-CoV-2 spike protein or other viral antigens contribute to Long COVID. Current evidence suggests that circulating spike levels alone do not consistently predict who develops symptoms, how severe they become, or whether someone will recover.
| Observed Pattern | What It Means |
|---|---|
| Some people have detectable or relatively high spike/antigen levels and feel well. | Detection alone does not prove active disease, tissue injury, or future symptoms. |
| Some people have low or undetectable circulating spike and significant Long COVID. | A blood result may miss tissue-localized antigen, or the illness may be driven mainly by other mechanisms. |
| Some patients report improvement when spike or antigen levels fall. | This may support an antigen-related mechanism in a subset, but does not prove that the reduction caused recovery. |
| Other patients have lower spike or antigen levels without symptom improvement. | Downstream immune, vascular, neurologic, autonomic, metabolic, or tissue changes may continue after the trigger declines. |
| Symptoms and spike levels may change independently. | Long COVID is heterogeneous; one marker is unlikely to represent every phenotype or mechanism. |
Spike Protein Is Not a Stand-Alone Diagnostic or Severity Marker
No standardized, FDA-authorized clinical spike assay has been validated to diagnose Long COVID, distinguish infection-derived from vaccine-derived spike in every situation, measure total tissue burden, determine illness severity, or select a proven “spike detox” treatment. Research assays differ in what they detect, how samples are processed, and how results are interpreted.
The Practical Takeaway
Spike persistence is a plausible and actively studied contributor for a subset of patients—not the sole cause of Long COVID and not a sufficient marker by itself. A patient’s symptoms, function, examination, history, and broader evaluation remain central.
Other Mechanisms Can Continue After an Initial Trigger
- Autoimmune responses may continue after antigen decreases
- Endothelial or tissue injury may require time to repair
- Autonomic circuits may remain dysregulated
- Latent viruses may reactivate
- Mitochondrial and metabolic changes may persist
- Sleep disruption, pain, inactivity, and nutritional deficiencies may become secondary maintaining factors
- More than one mechanism may be active simultaneously
Treatments for Long COVID
Long COVID treatment is highly individualized because no single therapy is effective for every patient. Our Long COVID Treatment Guide explains the prescription medications, supportive therapies, nutritional approaches, and other treatment options that may be considered based on your symptoms, overall health, and treatment goals. It also discusses the current evidence, important safety considerations, and common questions to help you better understand your options and make informed decisions in partnership with your APNS provider. Whether you are newly diagnosed or have been living with Long COVID for months or years, this guide is designed to help you better understand the treatments that may be appropriate for your care.
Ready to take control of Long COVID?
Whether you’re experiencing persistent symptoms after COVID-19 or looking for additional support after months or years of ongoing illness, APNS is here to help. Our providers will work with you to develop a personalized evaluation and treatment plan based on your symptoms, medical history, and individual needs, with the goal of improving function, quality of life, and long-term health.